当前位置:首页 - 行情中心 - 惠泰医疗(688617) - 财务分析

惠泰医疗

(688617)

  

流通市值:433.84亿  总市值:433.84亿
流通股本:1.41亿   总股本:1.41亿

惠泰医疗(688617)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年半年度实现净利润4.19亿元,每股收益3.02元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年半年度最新股东权益282927.97万元,未分配利润189341.59万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年半年度最新总资产322250.05万元,负债39322.08万元。

利润表
报告期2025-06-302025-03-312024-12-312024-09-30
营业总收入1,213,804,906.53564,276,710.672,065,801,597.741,524,828,925.89
营业总成本752,300,167.35357,739,406.51,339,013,056.93970,562,004.58
其他经营收益
营业利润483,304,979.16215,668,911.8753,691,427.41589,309,852.67
利润总额479,340,286.62213,819,515.86745,967,278.53586,766,450.36
净利润418,900,671.88180,135,141.87658,167,740.72522,050,612.64
每股收益
其他综合收益2,191,973.46-138,078.4-22,575,353.3410,593,158.2
综合收益总额421,092,645.34179,997,063.47635,592,387.38532,643,770.84
资产负债表
报告期2025-06-302025-03-312024-12-312024-09-30
流动资产:
流动资产合计1,781,575,753.241,750,830,787.651,616,687,606.561,469,496,563.41
非流动资产:
非流动资产合计1,440,924,761.171,393,761,981.581,364,010,162.261,334,424,607.91
资产总计3,222,500,514.413,144,592,769.232,980,697,768.822,803,921,171.32
流动负债:
流动负债合计348,102,859.99371,231,509.51405,968,659.57347,617,108.91
非流动负债:
非流动负债合计45,117,968.0736,906,749.1419,885,806.7220,190,162.85
负债合计393,220,828.06408,138,258.65425,854,466.29367,807,271.76
所有者权益(或股东权益):
归属于母公司股东权益合计2,794,367,389.652,700,953,801.472,516,339,545.432,388,153,365
股东权益合计2,829,279,686.352,736,454,510.582,554,843,302.532,436,113,899.56
负债和股东权益合计3,222,500,514.413,144,592,769.232,980,697,768.822,803,921,171.32
现金流量表
报告期2025-06-302025-03-312024-12-312024-09-30
经营活动产生的现金流量:
经营活动现金流入小计1,398,374,210.86661,666,868.332,321,424,686.741,702,544,374.27
经营活动现金流出小计953,725,557.93495,004,280.841,578,034,675.761,178,706,951.92
经营活动产生的现金流量净额444,648,652.93166,662,587.49743,390,010.98523,837,422.35
投资活动产生的现金流量:
投资活动现金流入小计1,212,932,925.25696,565,764.862,484,562,605.42362,194,716.19
投资活动现金流出小计1,478,864,010.4744,584,702.923,102,354,358.131,239,935,538.94
投资活动产生的现金流量净额-265,931,085.15-48,018,938.06-617,791,752.71-877,740,822.75
筹资活动产生的现金流量:
筹资活动现金流入小计27,373,979.28-91,033,523.5269,759,005.08
筹资活动现金流出小计224,066,169.412,856,896.05398,932,446.96390,158,565.9
筹资活动产生的现金流量净额-196,692,190.13-2,856,896.05-307,898,923.44-320,399,560.82
汇率变动对现金及现金等价物的影响2,149,549.56799,616.44-13,002,729.01-2,474,689.05
现金及现金等价物净增加额-15,825,072.79116,586,369.82-195,303,394.18-676,777,650.27
期末现金及现金等价物余额1,065,262,838.241,197,674,280.851,081,087,911.03599,613,654.94
补充资料:
现金及现金等价物的净增加额-15,825,072.79--195,303,394.18-
最新报告期:2025-08-27
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
太平洋谭紫媚6.388.4411.012025-08-27
方正证券周超泽6.438.2010.312025-08-27
国信证券陈曦炳6.218.0410.442025-08-26
平安证券叶寅,倪亦道,裴晓鹏6.278.1010.552025-08-25
招商证券梁广楷,许菲菲,郭子娴6.388.3110.882025-08-25
TOP↑